Related Experiment Video
Updated: Aug 24, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Improved antiviral activity in vitro of ribavirin against measles virus after complexation with cyclodextrins
Nicolas Grancher1, Véronique Venard, Francine Kedzierewicz
1Groupe d'Etude des Vecteurs Supramoléculaires du Médicament, Unité Mixte de Recherche Université-CNRS 7565, Structure et Réactivité des Systèmes Moléculaires Complexes, Université Henri Poincaré, Nancy 1, France. nicolas.grancher@wanadoo.fr
Abstract:
Despite vaccination, measles remains a burden in both developed and developing countries and complications may necessitate an efficient therapy. Measles virus (MEV) is susceptible to ribavirin (RBV), but the use of this drug is limited by its toxicity. Cyclodextrins (CDs) can form complexes with numerous molecules, improving their bioavailability and their biological properties. We have evaluated in vitro the antiviral effects of complexes of RBV with alpha-, beta- or gamma-CD against two clade A laboratory strains of MEV (Edmonston and CAM/RB) grown on Vero cells. Complexation of RBV with alpha-CD or beta-CD lead to a five-fold or a two-fold decrease in the 50% inhibitory concentration, respectively, against both MEV strains. In contrast, gamma-CD complexation showed no modification.
Related Concept Videos
Respiratory Syncytial Virus Disease
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Inhibitors Of Virion Release

